REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA

Clinical trials for REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 14 Not yet finished but already full! 7 Completed 1

New pill tested for tough blood cancers after other treatments fail

Disease control Completed

This early-stage study tested a new oral drug called LP-108, given alone or with another cancer drug (azacitidine), in adults with advanced blood cancers that had returned or did not respond to prior treatments. The main goals were to find a safe dose, see how the body processes …

Matched conditions: REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA

Phase: PHASE1 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA

Get alerted when new REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA trials appear

New pill tested for tough blood cancers after other treatments fail